| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Lu Cai | |
| Jun Cai | |||
| Yang Zheng | |||
| Quan Liu | |||
| Xia Yin | |||
| P2860 | cites work | Impaired glucose tolerance in sleep disorders | Q21091145 |
| Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q22306347 | ||
| Cardiomyocytes as effectors of nitric oxide signalling | Q24310604 | ||
| How mitochondria produce reactive oxygen species | Q24643882 | ||
| The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology | Q27860991 | ||
| From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state | Q28280396 | ||
| Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium | Q28304462 | ||
| Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction | Q48490969 | ||
| Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats | Q48547568 | ||
| Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study | Q48594462 | ||
| Nocturnal oxygen desaturation correlates with the severity of coronary atherosclerosis in coronary artery disease | Q48618871 | ||
| Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome | Q48643754 | ||
| Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxia | Q48694134 | ||
| Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study | Q48704784 | ||
| Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure | Q48741847 | ||
| Hemodynamic changes associated with obstructive sleep apnea followed by arousal in a porcine model | Q48860214 | ||
| Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats | Q48886060 | ||
| Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. | Q48919880 | ||
| Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. | Q51690158 | ||
| Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. | Q52563106 | ||
| Effects of intermittent hypoxia on action potential and contraction in non-ischemic and ischemic rat papillary muscle. | Q54031027 | ||
| Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. | Q54517994 | ||
| Cardioprotective effects of chronic hypoxia and ischaemic preconditioning are not additive | Q57110792 | ||
| Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias. Involvement of mitochondrial K(ATP) channel | Q57113816 | ||
| Eccentric cardiac hypertrophy was induced by long-term intermittent hypoxia in rats | Q60686148 | ||
| Childhood chronic illness: prevalence, severity, and impact | Q68058572 | ||
| Sensitive and nonenzymatic measurement of hydrogen peroxide in biological systems | Q73045635 | ||
| Hypertension caused by chronic intermittent hypoxia--influence of chemoreceptors and sympathetic nervous system | Q74261920 | ||
| [Antiarrhythmic and antioxidative effects of intermittent hypoxia exposure on rat myocardium] | Q77965781 | ||
| Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression | Q79363785 | ||
| Pediatric obstructive sleep apnea syndrome | Q80976834 | ||
| Enhancement of Na/K pump activity by chronic intermittent hypobaric hypoxia protected against reperfusion injury | Q83727082 | ||
| Intermittent hypobaric hypoxia improves postischemic recovery of myocardial contractile function via redox signaling during early reperfusion | Q84707514 | ||
| The cardioprotection of intermittent hypoxic adaptation | Q46947181 | ||
| Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice | Q47767899 | ||
| Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury | Q47849035 | ||
| Mal-effects of obstructive sleep apnea on the heart | Q48282401 | ||
| Tempol ameliorates pharyngeal dilator muscle dysfunction in a rodent model of chronic intermittent hypoxia | Q48286525 | ||
| Anti-oxidant treatment in obstructive sleep apnoea syndrome. | Q48288641 | ||
| Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia | Q48451162 | ||
| Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice | Q48478581 | ||
| Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia | Q48486252 | ||
| Prevalence of overweight and obesity in the United States, 1999-2004 | Q28305811 | ||
| Effects of short- and long-term hypobaric hypoxia on Bcl2 family in rat heart | Q28567182 | ||
| Role of oxidative stress in PKC-delta upregulation and cardioprotection induced by chronic intermittent hypoxia | Q28573379 | ||
| The occurrence of sleep-disordered breathing among middle-aged adults | Q29547889 | ||
| Prospective study of the association between sleep-disordered breathing and hypertension | Q29620492 | ||
| Disorders of glucose metabolism in sleep apnea. | Q30351634 | ||
| Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model | Q30500690 | ||
| Obstructive sleep apnea as a risk factor for type 2 diabetes | Q33565324 | ||
| Adult obstructive sleep apnea: pathophysiology and diagnosis | Q33619089 | ||
| Oxygen, oxidative stress, hypoxia, and heart failure | Q33683779 | ||
| Oxygen free radical signaling in ischemic preconditioning | Q33692395 | ||
| Protective effects of intermittent hypoxic adaptation on myocardium and its mechanisms | Q33736623 | ||
| Chronic intermittent hypobaric hypoxia protects the heart against ischemia/reperfusion injury through upregulation of antioxidant enzymes in adult guinea pigs | Q33859226 | ||
| Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling | Q33862454 | ||
| Epidemiology of obstructive sleep apnea: a population health perspective | Q34126856 | ||
| Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure | Q34180371 | ||
| Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice | Q34231667 | ||
| Invited review: Intermittent hypoxia and respiratory plasticity | Q34253397 | ||
| Intermittent hypoxia: cell to system | Q34336970 | ||
| Obstructive sleep apnea as a risk factor for stroke and death | Q34466726 | ||
| Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q34595917 | ||
| Redox signaling in cardiac myocytes. | Q34629326 | ||
| Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? | Q34663670 | ||
| Ventilatory changes during intermittent hypoxia: importance of pattern and duration. | Q34774122 | ||
| Obstructive sleep apnoea syndrome--an oxidative stress disorder | Q35066278 | ||
| Oxidant signals and oxidative stress | Q35089394 | ||
| New concepts in reactive oxygen species and cardiovascular reperfusion physiology | Q35666898 | ||
| Molecular mechanisms of cardiac protection by adaptation to chronic hypoxia. | Q35761344 | ||
| Oxidative stress during myocardial ischaemia and heart failure. | Q35768626 | ||
| Reactive oxygen signalling: the latest news | Q35768826 | ||
| The Nox family of NAD(P)H oxidases: host defense and beyond | Q35886272 | ||
| Nitrosative stress and pharmacological modulation of heart failure | Q36145124 | ||
| Myocardial substrate metabolism in the normal and failing heart | Q36179008 | ||
| Endoscopic percutaneous dilatational tracheotomy: a prospective evaluation of 500 consecutive cases | Q36287803 | ||
| Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach | Q36294346 | ||
| Chronic intermittent hypoxia induces atherosclerosis | Q36330538 | ||
| Reducing infarct size in the setting of acute myocardial infarction | Q36454590 | ||
| Hydrogen peroxide: a signaling messenger | Q36469258 | ||
| Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease | Q36726274 | ||
| Relevance of nitric oxide for myocardial remodeling. | Q36770499 | ||
| Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury | Q36852069 | ||
| ROS signaling in systemic and cellular responses to chronic intermittent hypoxia | Q36879180 | ||
| The epidemiology of adult obstructive sleep apnea | Q37077140 | ||
| Alterations in Glucose Disposal in Sleep-disordered Breathing | Q37077794 | ||
| Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease | Q37275639 | ||
| Intermittent hypoxia and respiratory plasticity in humans and other animals: does exposure to intermittent hypoxia promote or mitigate sleep apnoea? | Q37342454 | ||
| Chronic intermittent hypoxia increases left ventricular contractility in C57BL/6J mice. | Q37372426 | ||
| Sleep-Disordered Breathing in Community-Dwelling Elderly | Q37375065 | ||
| Mitochondria and reactive oxygen species | Q37475734 | ||
| Hypertension in obstructive sleep apnea: risk and therapy | Q37510986 | ||
| NADPH oxidases in cardiovascular disease. | Q37742824 | ||
| Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications | Q37826498 | ||
| Update: systemic diseases and the cardiovascular system (i): obesity and the heart | Q37833332 | ||
| Obstructive sleep apnea syndrome and cardiovascular diseases | Q37860237 | ||
| Obesity, obstructive sleep apnoea and metabolic syndrome | Q37944926 | ||
| Hydrogen peroxide is the major oxidant product of xanthine oxidase | Q39867331 | ||
| Oxidants as stimulators of signal transduction | Q41260199 | ||
| Intermittent hypoxia protects the rat heart against ischemia/reperfusion injury by activating protein kinase C. | Q42467454 | ||
| Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity | Q42738504 | ||
| Redox-sensitive prosurvival and proapoptotic protein expression in the myocardial remodeling post-infarction in rats. | Q43115229 | ||
| Pitavastatin reduces oxidative stress and attenuates intermittent hypoxia-induced left ventricular remodeling in lean mice | Q43124445 | ||
| Increased resistance to hydrogen peroxide-induced cardiac contracture is associated with decreased myocardial oxidative stress in hypothyroid rats | Q43249700 | ||
| Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart | Q43570248 | ||
| Chronic intermittent hypoxia elicits serotonin-dependent plasticity in the central neural control of breathing. | Q43662879 | ||
| H(2)O(2) opens mitochondrial K(ATP) channels and inhibits GABA receptors via protein kinase C-epsilon in cardiomyocytes | Q43917359 | ||
| Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies | Q44015014 | ||
| Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats | Q44088301 | ||
| Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome | Q44178011 | ||
| ATP-dependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury | Q44506021 | ||
| Intermittent hypoxia increases insulin resistance in genetically obese mice | Q44524266 | ||
| Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations | Q44554087 | ||
| Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention | Q44564845 | ||
| Intermittent hypoxic training protects canine myocardium from infarction. | Q45037189 | ||
| Chronic intermittent hypoxia increases infarction in the isolated rat heart. | Q45200745 | ||
| Effects of allopurinol on cardiac function and oxidant stress in chronic intermittent hypoxia. | Q45929028 | ||
| Effect of chronic intermittent hypobaric hypoxia on α(1)-adrenergic receptor of myocardium participates in the cardioprotection. | Q46118835 | ||
| Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy | Q46853314 | ||
| Effects of different modes of intermittent hypobaric hypoxia on ischemia/reperfusion injury in developing rat hearts. | Q46947166 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| inorganic compound | Q190065 | ||
| physiological phenomenon | Q66615932 | ||
| physiological adaptation | Q67080983 | ||
| biological adaptation | Q67504163 | ||
| P304 | page(s) | 569520 | |
| P577 | publication date | 2012-05-20 | |
| P1433 | published in | Oxidative medicine and cellular longevity | Q26840015 |
| P1476 | title | Cardiac response to chronic intermittent hypoxia with a transition from adaptation to maladaptation: the role of hydrogen peroxide | |
| P478 | volume | 2012 |
| Q35827630 | Alterations in left ventricular function during intermittent hypoxia: Possible involvement of O-GlcNAc protein and MAPK signaling |
| Q59336176 | Association of sleep problems with neuroendocrine hormones and coagulation factors in patients with acute myocardial infarction |
| Q91725399 | Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway |
| Q36933096 | Cardiorespiratory coupling in health and disease |
| Q92619499 | Combination of Broccoli Sprout Extract and Zinc Provides Better Protection against Intermittent Hypoxia-Induced Cardiomyopathy Than Monotherapy in Mice |
| Q34079885 | Deletion of metallothionein exacerbates intermittent hypoxia-induced oxidative and inflammatory injury in aorta |
| Q35673392 | Effects of rhodiola crenulata on mice hearts under severe sleep apnea |
| Q37340192 | Exercise Attenuates Intermittent Hypoxia-Induced Cardiac Fibrosis Associated with Sodium-Hydrogen Exchanger-1 in Rats |
| Q52609028 | Intermittent hypoxia induces beneficial cardiovascular remodeling in left ventricular function of type 1 diabetic rat. |
| Q47700383 | Intermittent hypoxia-induced cardiomyopathy and its prevention by Nrf2 and metallothionein |
| Q36747612 | Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice. |
| Q29248021 | Re-evaluation of the WHO (2010) formaldehyde indoor air quality guideline for cancer risk assessment |
| Q86513791 | Sheng-Mai-San attenuates contractile dysfunction and structural damage induced by chronic intermittent hypoxia in mice |
| Q41672064 | Tauroursodeoxycholic acid attenuates endoplasmic reticulum stress and protects the liver from chronic intermittent hypoxia induced injury |
Search more.